Pepticom is a biotechnology company specializing in the development of peptide-based therapeutics. The company utilizes advanced computational algorithms and artificial intelligence to design and optimize peptides for various applications, including drug discovery and development. Pepticom's innovative approach aims to streamline the process of identifying and creating effective peptide candidates, addressing challenges in areas such as oncology, immunology, and other therapeutic fields. The company is focused on enhancing the efficacy and specificity of peptide drugs while reducing development costs and time.